These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS; Wong KY; Loong F; Lam WW; Srivastava G Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
6. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer. Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012 [TBL] [Abstract][Full Text] [Related]
7. [Abnormal methylation of several tumor suppressor genes in sporadic breast cancer]. Zemliakova VV; Zhevlova AI; Strel'nikov VV; Liubchenko LN; Vishnevskaia IaV; Tret'iakova VA; Zaletaev DV; Nemtsova MV Mol Biol (Mosk); 2003; 37(4):696-703. PubMed ID: 12942643 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Chim CS; Wong AS; Kwong YL Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284 [TBL] [Abstract][Full Text] [Related]
9. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes. Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049 [TBL] [Abstract][Full Text] [Related]
10. Frequent alterations of cell-cycle regulators in astrocytic tumors as detected by molecular genetic and immunohistochemical analyses. Nakamura M; Konishi N; Hiasa Y; Tsunoda S; Nakase H; Tsuzuki T; Aoki H; Sakitani H; Inui T; Sakaki T Brain Tumor Pathol; 1998; 15(2):83-8. PubMed ID: 10328544 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme. Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207 [TBL] [Abstract][Full Text] [Related]
12. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005 [TBL] [Abstract][Full Text] [Related]
13. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival. Puduvalli VK; Kyritsis AP; Hess KR; Bondy ML; Fuller GN; Kouraklis GP; Levin VA; Bruner JM Int J Oncol; 2000 Nov; 17(5):963-9. PubMed ID: 11029499 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Kim YH; Lachuer J; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nobusawa S; Nakazato Y; Tanaka Y; Vital A; Mariani L; Ohgaki H Brain Pathol; 2011 Nov; 21(6):645-51. PubMed ID: 21470325 [TBL] [Abstract][Full Text] [Related]
16. CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex. Alves MK; Faria MH; Neves Filho EH; Ferrasi AC; Pardini MI; de Moraes Filho MO; Rabenhorst SH Int J Surg; 2013; 11(7):549-53. PubMed ID: 23721661 [TBL] [Abstract][Full Text] [Related]
17. Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. Schmidt EE; Ichimura K; Messerle KR; Goike HM; Collins VP Br J Cancer; 1997; 75(1):2-8. PubMed ID: 9000591 [TBL] [Abstract][Full Text] [Related]
18. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between p16 and Rb protein expression in astrocytomas]. Lin Y; Huang C; Liu D Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):340-2. PubMed ID: 10374322 [TBL] [Abstract][Full Text] [Related]
20. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]